Tag Archives: Swayampakula Ramakanth

H.C. Wainwright Keeps Their Buy Rating on Vascular Biogenics (VBLT)

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Vascular Biogenics (VBLT – Research Report) on April 2 and set a price target of $3.00. The company’s shares closed last Friday at $1.16. According to TipRanks.com, Ramakanth has currently

AB Science SA (ABSCF) Initiated with a Buy at H.C. Wainwright

AB Science SA (ABSCF – Research Report) received a Buy rating and a EUR9.00 price target from H.C. Wainwright analyst Swayampakula Ramakanth today. The company’s shares closed last Monday at $6.90. According to TipRanks.com, Ramakanth has currently no stars on

Analysts Offer Insights on Healthcare Companies: IntelGenx Technologies (Other OTC: IGXT), Aerpio Pharmaceuticals (NASDAQ: ARPO) and Medtronic (NYSE: MDT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IntelGenx Technologies (IGXT – Research Report), Aerpio Pharmaceuticals (ARPO – Research Report) and Medtronic (MDT – Research Report). IntelGenx Technologies (IGXT) In a

Codexis (CDXS) Gets a Buy Rating from H.C. Wainwright

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Codexis (CDXS – Research Report), with a price target of $22.50. The company’s shares closed last Monday at $11.20. According to TipRanks.com, Ramakanth ‘s ranking

H.C. Wainwright Reiterates Their Buy Rating on CASI Pharmaceuticals (CASI)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on CASI Pharmaceuticals (CASI – Research Report), with a price target of $3.50. The company’s shares closed last Monday at $1.70. According to TipRanks.com, Ramakanth has

H.C. Wainwright Remains a Buy on Vascular Biogenics (VBLT)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Vascular Biogenics (VBLT – Research Report), with a price target of $3.00. The company’s shares closed last Monday at $1.04. According to TipRanks.com, Ramakanth has